A meta-analysis shows GLP-1 RA therapy does not significantly lower vascular dementia events compared with placebo in high-risk patient groups.

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitor use may reduce the risk for Alzheimer’s disease, Parkinson’s disease and vascular dementia. The ...

The factors that raise the risk of heart disease and stroke can also raise the risk of dementia. When blood vessels are damaged or blocked, it can deprive your brain of vital oxygen and nutrients, and ...

Different types of conditions fall under the umbrella of dementia. There’s the most common form, Alzheimer’s disease, but also lesser-known types like frontotemporal dementia and dementia with Lewy ...

A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the University of Vermont Robert Larner, M.D. College of Medicine provides ...

Popular diabetes and weight loss drug, semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. The corresponding study was published in ...

For confidential advice, call Alzheimer's Society's Dementia Support Line on 0333 150 3456 Alzheimer's Society's symptoms checker can help spot the signs of dementia After almost 40 years in nursing, ...

GLP-1 therapy may lower CKD dementia risk and Alzheimer’s incidence in diabetic patients. Explore the latest evidence and clinical implications.

High body mass index is causally linked to an increased risk of vascular-related dementia, according to a Mendelian randomization study.

Whether you have any of the symptoms or not, there are things you can do to reduce your dementia risk.